|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Furiex Pharmaceuticals, Inc. (FURX) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
10,015,000 |
Market
Cap: |
N/A |
Last
Volume: |
49,855 |
Avg
Vol: |
49,713 |
52
Week Range: |
$106.18 - $106.18 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Corr Peter B |
Director |
|
2014-07-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,447) |
0 |
|
- |
|
Actavis Plc |
10% Owner |
|
2014-07-02 |
4 |
B |
$95.00 |
$1,061,061,270 |
D/D |
11,169,066 |
0 |
2.45 |
- |
|
Dixon Wendy L |
Director |
|
2014-07-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,160) |
0 |
|
- |
|
Mcintyre Gail Frances |
Senior Vice President-Research |
|
2014-07-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(24,318) |
0 |
|
- |
|
Patel Sailash |
Chief Financial Officer |
|
2014-07-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(26,444) |
0 |
|
- |
|
Eshelman Fredric N |
Director |
|
2014-07-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(174,495) |
0 |
|
- |
|
Eshelman Fredric N |
Director |
|
2014-07-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,673,522) |
0 |
|
- |
|
Covington Paul S |
Senior VP-Clinical Operations |
|
2014-07-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,523) |
0 |
|
- |
|
Kaldor Stephen W |
Director |
|
2014-07-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,160) |
0 |
|
- |
|
Davis Stephen |
Director |
|
2014-07-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,308) |
0 |
|
- |
|
Almenoff June Sherie |
President |
|
2014-07-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(24,600) |
0 |
|
- |
|
Patel Sailash |
Chief Financial Officer |
|
2014-06-24 |
4 |
S |
$104.00 |
$3,424,512 |
D/D |
(32,928) |
26,444 |
|
- |
|
Patel Sailash |
Chief Financial Officer |
|
2014-06-24 |
4 |
OE |
$9.11 |
$299,974 |
D/D |
32,928 |
59,372 |
|
- |
|
Covington Paul S |
Senior VP-Clinical Operations |
|
2014-06-24 |
4 |
S |
$104.12 |
$1,079,516 |
D/D |
(10,368) |
22,523 |
|
- |
|
Covington Paul S |
Senior VP-Clinical Operations |
|
2014-06-24 |
4 |
OE |
$17.80 |
$184,550 |
D/D |
10,368 |
32,891 |
|
- |
|
Covington Paul S |
Senior VP-Clinical Operations |
|
2014-06-18 |
4 |
S |
$104.11 |
$4,756,890 |
D/D |
(45,691) |
22,523 |
|
- |
|
Covington Paul S |
Senior VP-Clinical Operations |
|
2014-06-18 |
4 |
OE |
$9.11 |
$416,245 |
D/D |
45,691 |
68,214 |
|
- |
|
Mcintyre Gail Frances |
Senior Vice President-Research |
|
2014-06-17 |
4 |
S |
$105.00 |
$840,840 |
D/D |
(8,008) |
24,318 |
|
- |
|
Mcintyre Gail Frances |
Senior Vice President-Research |
|
2014-06-17 |
4 |
OE |
$13.16 |
$105,385 |
D/D |
8,008 |
32,326 |
|
- |
|
Mcintyre Gail Frances |
Senior Vice President-Research |
|
2014-06-16 |
4 |
S |
$105.00 |
$6,977,591 |
D/D |
(66,449) |
24,318 |
|
- |
|
Mcintyre Gail Frances |
Senior Vice President-Research |
|
2014-06-16 |
4 |
OE |
$9.11 |
$738,890 |
D/D |
62,645 |
28,035 |
|
- |
|
Covington Paul S |
Senior VP-Clinical Operations |
|
2014-06-13 |
4 |
S |
$104.25 |
$336,519 |
D/D |
(3,228) |
22,523 |
|
- |
|
Covington Paul S |
Senior VP-Clinical Operations |
|
2014-06-10 |
4 |
S |
$104.63 |
$300,497 |
D/D |
(2,872) |
25,751 |
|
- |
|
Patel Sailash |
Chief Financial Officer |
|
2014-06-10 |
4 |
S |
$104.68 |
$157,439 |
D/D |
(1,504) |
26,444 |
|
- |
|
Mcintyre Gail Frances |
Senior Vice President-Research |
|
2014-06-10 |
4 |
S |
$104.58 |
$182,597 |
D/D |
(1,746) |
28,122 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|